Bwx Technologies Inc Stock Price, News & Analysis

BWX Technologies, Inc. (BWXT) has announced a webcast to discuss its first quarter 2021 results on May 4, 2021, at 9:00 a.m. EDT. A press release detailing the results will follow after market close on May 3.

Listeners can join via www.bwxt.com/investors. Dial-in numbers for participants are (U.S.) 844-850-0542 and (International) 412-317-6014. A replay will be available on the BWXT website for a limited time.

BWX Technologies, Inc. (NYSE: BWXT) has successfully closed a $400 million offering of 4.125% senior notes due 2029. The Notes are guaranteed by its wholly owned subsidiaries. Proceeds will be utilized to redeem the outstanding 5.375% senior notes due 2026 and repay credit facility debt. Any remaining funds will be held in cash or short-term investments. The release includes forward-looking statements and cautions against undue reliance on them. Further risk factors can be found in BWXT's SEC filings.

BWX Technologies, Inc. (NYSE: BWXT) has secured a contract extension valued at up to $690 million from the U.S. Department of Energy (DOE) for environmental management work at the Portsmouth Gaseous Diffusion Plant. This extension, effective March 29, 2021, includes a one-year term with two additional six-month options. The contract involves decontamination, demolition, and ongoing environmental remediation at the site, which was operational from 1954 to 2001. BWXT expresses confidence in its capabilities, highlighting its extensive experience in supporting DOE's Environmental Management mission.

BWX Technologies, Inc. (NYSE: BWXT) continues its Nuclear Thermal Propulsion (NTP) development for NASA with a new $9.4 million contract awarded to its subsidiary, BWXT Advanced Technologies LLC. The contract focuses on nuclear fuel design and engineering, including the production and coating of fuel kernels, as well as reactor design. The work will be executed at several BWXT facilities with a team of over 50 employees. This contract builds on BWXT's ongoing efforts in space propulsion technology aimed at enabling crewed missions to Mars.

BWX Technologies, Inc. (NYSE: BWXT) has priced its offering of $400 million in 4.125% senior notes due 2029. The offering aims to redeem the outstanding 5.375% senior notes due 2026, utilizing the net proceeds, along with cash or borrowings. The completion of the notes offering is expected on April 13, 2021, subject to customary closing conditions. The notes are offered under Rule 144A and Regulation S and are not registered under the Securities Act. BWXT warns of potential risks and uncertainties related to the offering's success and market demand.

BWX Technologies, Inc. (NYSE: BWXT) has announced plans to offer up to $400 million in senior notes due 2029, exempt from registration under the Securities Act. The proceeds will be used to redeem outstanding 5.375% senior notes due 2026 and to repay debt under its credit facility. The offering is targeted at qualified institutional buyers. BWXT warns that forward-looking statements in the release could vary due to economic conditions and market demand. The company emphasizes its role in providing nuclear solutions for various sectors.

BWX Technologies, Inc. (NYSE: BWXT) has secured a $28 million contract from the Department of Defense’s Strategic Capabilities Office to develop a transportable microreactor prototype as part of Project Pele. This contract follows a $14 million award for initial design work in 2020. The microreactor aims to provide resilient power for various DoD operations and enhance energy logistics without increasing carbon emissions. BWXT's expertise in innovative designs and proven production techniques positions it strongly in the microreactor market. Work will commence in March 2021 at BWXT’s Virginia facility.

BWX Technologies, Inc. (NYSE: BWXT) announced $35 million in contracts awarded to its subsidiary, BWXT Nuclear Operations Group, for uranium recovery and conversion and research reactor fuel line construction. The U.S. Naval Nuclear Propulsion Program awarded a $17.4 million contract for uranium recovery, while the U.S. Department of Energy’s NNSA awarded $17.9 million for a HALEU fuel project. These projects leverage BWXT's expertise in nuclear fuel processing and support global security by promoting nonproliferation.

BWXT Medical and Global Medical Solutions have formed a joint venture (JV) to create a reliable supply of radioisotopes and radiopharmaceuticals in the Asia-Pacific region. BWXT Medical plans to replicate its North American operations in Asia, focusing on technetium-99m (Tc-99m) generators, which are crucial for over 40 million diagnostic imaging procedures worldwide annually. The JV aims to alleviate Asia's reliance on European and U.S. supplies, enhancing service reliability. Initial investment is expected to begin in 2023, with both companies optimistic about meeting rising demand.